Completed NA INTERVENTIONAL 1-arm NCT02888717

Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers (GYNOSNA)

Concordance Study of Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers (GYNOSNA)

Sponsor: Institut Cancerologie de l'Ouest

Conditions Advanced Cervical Cancer

Interventions 'OSNA stadification during surgery'

Updated 8 times since 2017 Last updated: Mar 23, 2020 Started: Apr 28, 2015 Primary completion: Nov 13, 2018 Completion: Nov 13, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02888717, this NA trial focuses on Advanced Cervical Cancer and remains completed. Sponsored by Institut Cancerologie de l'Ouest, it has been updated 8 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2019 — Apr 2020 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting · Phase: PHASE2 → NA

▶ Show 3 earlier versions

Sep 2018 — Feb 2019 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE2
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Cancerologie de l'Ouest

Data source: Institut Cancerologie de l'Ouest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint-Herblain, France